Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies

References

• Bontenbal M, Sieuwerts A M, Klijn J G, Peters H A, Krijnen H L, Sonneveld P, Foekens J A. Effect of hormonal manipulation and doxorubicin administration on cell cycle kinetics of human breast cancer cells. Br J Cancer 1989; 60: 688–692
   PubMed Web of Science ®Google Scholar
• Bowker S L, Majumdar S R, Veugelers P, Johnson J A. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006; 29: 254–258
   PubMed Web of Science ®Google Scholar
• Bruning P F, Bonfrèr J M, van Noord P A, Hart A A, de Jong-Bakker M, Nooijen W J. Insulin resistance and breast-cancer risk. Int J Cancer 1992; 52: 511–516
   PubMed Web of Science ®Google Scholar
• Buzzai M, Jones R G, Amaravadi R K, Lum J J, DeBerardinis R J, Zhao F, Viollet B, Thompson C B. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007; 67: 6745–6752
   PubMed Web of Science ®Google Scholar
• Calle E E, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579–591
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Abbà C, Ambroggio S, Peris C. Differential effects of progestins on the circulating IGF-I system. Maturitas 2003; 46(Suppl 1)S39–S44
   PubMedGoogle Scholar
• Cust A E, Allen N E, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault M C, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quirós J R, Agudo A, S´nchez M J, Larrañaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita H B, Peeters P H, van Gils C H, Bingham S, Khaw K T, Key T, Slimani N, Riboli E, Kaaks R. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 2007; 120: 2656–2664
   PubMed Web of Science ®Google Scholar
• Del Giudice M E, Fantus I G, Ezzat S, McKeown-Eyssen G, Page D, Goodwin P J. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 1998; 47: 111–120
   PubMed Web of Science ®Google Scholar
• Eliassen A H, Tworoger S S, Mantzoros C S, Pollak M N, Hankinson S E. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 2007; 16: 161–164
   PubMed Web of Science ®Google Scholar
• Evans J M, Donnelly L A, Emslie-Smith A M, Alessi D R, Morris A D. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005; 330: 1304–1305
   PubMed Web of Science ®Google Scholar
• Falk R T, Brinton L A, Madigan M P, Potischman N, Sturgeon S R, Malone K E, Daling J R. Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 2006; 98: 157–165
   PubMed Web of Science ®Google Scholar
• Frasca F, Pandini G, Malaguarnera R, Mandarino A, Messina R L, Sciacca L, Belfiore A, Vigneri R. Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling. J Biol Chem 2007; 282: 26077–26088
   PubMed Web of Science ®Google Scholar
• Gapstur S M, Gann P H, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000; 283: 2552–2558
   PubMed Web of Science ®Google Scholar
• Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131(11 Suppl)3109S–3120S
   PubMed Web of Science ®Google Scholar
• Jee S H, Ohrr H, Sull J W, Yun J E, Ji M, Samet J M. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194–202
   PubMed Web of Science ®Google Scholar
• Jenab M, Riboli E, Cleveland R J, Norat T, Rinaldi S, Nieters A, Biessy C, Tjønneland A, Olsen A, Overvad K, Grønbaek H, Clavel-Chapelon F, Boutron-Ruault M C, Linseisen J, Boeing H, Pischon T, Trichopoulos D, Oikonomou E, Trichopoulou A, Panico S, Vineis P, Berrino F, Tumino R, Masala G, Peters P H, van Gils C H, Bueno-de-Mesquita H B, Ocké M C, Lund E, Mendez M A, Tormo M J, Barricarte A, Martínez-García C, Dorronsoro M, Quirós J R, Hallmans G, Palmqvist R, Berglund G, Manjer J, Key T, Allen N E, Bingham S, Khaw K T, Cust A, Kaaks R. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121: 368–376
   PubMed Web of Science ®Google Scholar
• Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore R E, Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592–1600
   PubMed Web of Science ®Google Scholar
• Khaw K T, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer – Norfolk study. Cancer Epidemiol Biomarkers Prev 2004; 13: 915–919
   PubMed Web of Science ®Google Scholar
• Limburg P J, Stolzenberg-Solomon R Z, Vierkant R A, Roberts K, Sellers T A, Taylor P R, Virtamo J, Cerhan J R, Albanes D. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol 2006; 4: 1514–1521
   PubMed Web of Science ®Google Scholar
• Lukanova A, Zeleniuch–Jacquotte A, Lundin E, Micheli A, Arslan A A, Rinaldi S, Muti P, Lenner P, Koenig K L, Biessy C, Krogh V, Riboli E, Shore R E, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R. Prediagnostic levels of C-peptide, IGF-I, IGFBP-1, -2 and -3 and risk of endometrial cancer. Int J Cancer 2004; 108: 262–268
   PubMed Web of Science ®Google Scholar
• Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano J M, Stampfer M J. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96: 546–553
   PubMed Web of Science ®Google Scholar
• Malin A, Dai Q, Yu H, Shu X O, Jin F, Gao Y T, Zheng W. Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 2004; 100(4)694–700
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–748
   PubMed Web of Science ®Google Scholar
• Michaud D S, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson J E, Pollak M N, Ma J, Fuchs C S. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007; 16: 2101–2109
   PubMed Web of Science ®Google Scholar
• Muti P, Quattrin T, Grant B J, Krogh V, Micheli A, Schünemann H J, Ram M, Freudenheim J L, Sieri S, Trevisan M, Berrino F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1361–1368
   PubMed Web of Science ®Google Scholar
• Nilsen Lund T I, Vatten L J. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001; 84: 417–422
   PubMed Web of Science ®Google Scholar
• Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S, Japan Public Health Center–based Prospective Study Group. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer 2007; 120: 2007–2012
   PubMed Web of Science ®Google Scholar
• Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 2002; 277: 39684–39695
   PubMed Web of Science ®Google Scholar
• Pike M C, Pearce C L, Wu A H. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004; 23: 6379–6391
   PubMed Web of Science ®Google Scholar
• Platz E A, Giovannucci E. Prostate Cancer. Cancer Epidemiology and Prevention, 3rd ed, D Schottenfeld, J F Fraumeni. Oxford University Press, New York 2006; 1128–1150
   Google Scholar
• Renehan A G, Frystyk J, Howell A, O'dwyer S T, Shalet S M, Flyvbjerg A. The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides. Growth Horm IGF Res 2007; 17: 210–219
   PubMed Web of Science ®Google Scholar
• Renehan A G, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006; 17: 328–336
   PubMed Web of Science ®Google Scholar
• Renehan A G, Zwahlen M, Minder C, O'Dwyer S T, Shalet S M, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346–1353
   PubMed Web of Science ®Google Scholar
• Renehan A G, Tyson M, Egger M, Heller R F, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569–578
   PubMed Web of Science ®Google Scholar
• Saydah S H, Platz E A, Rifai N, Pollak M N, Brancati F L, Helzlsouer K J. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 412–418
   PubMed Web of Science ®Google Scholar
• Schairer C, Hill D, Sturgeon S R, Fears T, Pollak M, Mies C, Ziegler R G, Hoover R N, Sherman M E. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer 2004; 108: 773–779
   PubMed Web of Science ®Google Scholar
• Schoen R E, Tangen C M, Kuller L H, Burke G L, Cushman M, Tracy R P, Dobs A, Savage P J. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147–1154
   PubMed Web of Science ®Google Scholar
• Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E. Obesity and colon cancer: does leptin provide a link?. Int J Cancer 2004; 109: 149–152
   PubMed Web of Science ®Google Scholar
• Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, Kaaks R, Stattin P. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 2008; 32: 304–314
   PubMed Web of Science ®Google Scholar
• Stolzenberg-Solomon R Z, Graubard B I, Chari S, Limburg P, Taylor P R, Virtamo J, Albanes D. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 2005; 294: 2872–2878
   PubMed Web of Science ®Google Scholar
• Toniolo P, Bruning P F, Akhmedkhanov A, Bonfrer J M, Koenig K L, Lukanova A, Shore R E, Zeleniuch-Jacquotte A. Serum insulin-like growth factor-I and breast cancer. Int J Canc 2000; 88: 828–832
   PubMed Web of Science ®Google Scholar
• Tripkovic I, Tripkovic A, Strnad M, Capkun V, Zekan L. Role of insulin-like growth factor-1 in colon cancerogenesis: a case-control study. Arch Med Res 2007; 38: 519–525
   PubMed Web of Science ®Google Scholar
• Troisi R, Potischman N, Hoover R N, Siiteri P, Brinton L A. Insulin and endometrial cancer. Am J Epidemiol 1997; 146: 476–482
   PubMed Web of Science ®Google Scholar
• Verheus M, Peeters P H, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjønneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Téhard B, Nagel G, Linseisen J, Boeing H, Lahmann P H, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D, Tumino R, Panico S, Sacerdote C, Sieri S, van Gils C H, Bueno-de-Mesquita B H, Gonz´lez C A, Ardanaz E, Larranaga N, Garcia C M, Navarro C, Quirós J R, Key T, Allen N, Bingham S, Khaw K T, Slimani N, Riboli E, Kaaks R. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006; 119: 659–667
   PubMed Web of Science ®Google Scholar
• Wei E K, Ma J, Pollak M N, Rifai N, Fuchs C S, Hankinson S E, Giovannucci E. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005; 14: 850–855
   PubMed Web of Science ®Google Scholar
• Weiderpass E, Brismar K, Bellocco R, Vainio H, Kaaks R. Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer 2003; 89: 1697–1704
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund/American Institute for Cancer research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. IACR, Washington, DC 2007; 370
   Google Scholar
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. WHO, Geneva 1999
   Google Scholar